Literature DB >> 23843123

A multi-criteria decision analysis perspective on the health economic evaluation of medical interventions.

Douwe Postmus1, Tommi Tervonen, Gert van Valkenhoef, Hans L Hillege, Erik Buskens.   

Abstract

A standard practice in health economic evaluation is to monetize health effects by assuming a certain societal willingness-to-pay per unit of health gain. Although the resulting net monetary benefit (NMB) is easy to compute, the use of a single willingness-to-pay threshold assumes expressibility of the health effects on a single non-monetary scale. To relax this assumption, this article proves that the NMB framework is a special case of the more general stochastic multi-criteria acceptability analysis (SMAA) method. Specifically, as SMAA does not restrict the number of criteria to two and also does not require the marginal rates of substitution to be constant, there are problem instances for which the use of this more general method may result in a better understanding of the trade-offs underlying the reimbursement decision-making problem. This is illustrated by applying both methods in a case study related to infertility treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23843123     DOI: 10.1007/s10198-013-0517-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  14 in total

1.  Representing uncertainty: the role of cost-effectiveness acceptability curves.

Authors:  E Fenwick; K Claxton; M Sculpher
Journal:  Health Econ       Date:  2001-12       Impact factor: 3.046

2.  On the economic foundations of CEA. Ladies and gentlemen, take your positions!

Authors:  W B Brouwer; M A Koopmanschap
Journal:  J Health Econ       Date:  2000-07       Impact factor: 3.883

3.  Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

Authors:  Hans-Georg Eichler; Sheldon X Kong; William C Gerth; Panagiotis Mavros; Bengt Jönsson
Journal:  Value Health       Date:  2004 Sep-Oct       Impact factor: 5.725

4.  Multicriteria benefit-risk assessment using network meta-analysis.

Authors:  Gert van Valkenhoef; Tommi Tervonen; Jing Zhao; Bert de Brock; Hans L Hillege; Douwe Postmus
Journal:  J Clin Epidemiol       Date:  2011-12-23       Impact factor: 6.437

5.  Mathematical programming for the efficient allocation of health care resources.

Authors:  A A Stinnett; A D Paltiel
Journal:  J Health Econ       Date:  1996-10       Impact factor: 3.883

6.  Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.

Authors:  Maiwenn J Al; Talitha L Feenstra; Ben A van Hout
Journal:  Health Econ       Date:  2005-07       Impact factor: 3.046

7.  A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysis.

Authors:  Tommi Tervonen; Gert van Valkenhoef; Erik Buskens; Hans L Hillege; Douwe Postmus
Journal:  Stat Med       Date:  2011-01-26       Impact factor: 2.373

8.  Multiple criteria decision analysis for health technology assessment.

Authors:  Praveen Thokala; Alejandra Duenas
Journal:  Value Health       Date:  2012-10-06       Impact factor: 5.725

9.  Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.

Authors:  Mireille M Goetghebeur; Monika Wagner; Hanane Khoury; Randy J Levitt; Lonny J Erickson; Donna Rindress
Journal:  Med Decis Making       Date:  2011-10-10       Impact factor: 2.583

10.  Costs, effects and C/E-ratios alongside a clinical trial.

Authors:  B A van Hout; M J Al; G S Gordon; F F Rutten
Journal:  Health Econ       Date:  1994 Sep-Oct       Impact factor: 3.046

View more
  2 in total

1.  Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space.

Authors:  Nikki McCaffrey; Meera Agar; Janeane Harlum; Jonathon Karnon; David Currow; Simon Eckermann
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

2.  Using a stated preference discrete choice experiment to assess societal value from the perspective of patients with rare diseases in Italy.

Authors:  Julio López-Bastida; Juan Manuel Ramos-Goñi; Isaac Aranda-Reneo; Domenica Taruscio; Armando Magrelli; Panos Kanavos
Journal:  Orphanet J Rare Dis       Date:  2019-06-26       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.